- Canada needs small-scale vaccine manufacturing to support research, and help save human and animal lives
It is critical to accelerate the development of Canadian vaccine technologies—and in the timeframes necessary—to support new vaccine commercialization and help enable emergency preparedness.
- TB in bison studied at LFCE and VIDO-InterVac
A Parks Canada scientist is conducting research at the University of Saskatchewan (USask) on bovine tuberculosis in bison to improve diagnosis of the disease and to develop better vaccines.
- Dr. Andy Potter among Saskatchewan Order of Merit recipients
Dr. Potter is one of six people to receive the province's highest honour this year.
- Reverse vaccinology approach for novel bovine tuberculosis vaccines: The Canadian ReVAMP project
Researchers are taking a reverse vaccinology approach to develop new vaccines against bTB. Read more in the OiE Panorama, Controlling bovine tuberculosis: a One Health challenge
- Efforts to Create ASF Vaccines Result in Cautious Optimism
VIDO-InterVac scientists, in partnership with the Canadian Food Inspection Agency and partners in Kenya where African Swine Fever is present in pigs, have been working to develop vaccines to protect against the virus.
- U of Sask. could help prepare for outbreaks by producing human vaccines for Canada, centre director says
Canadians would be forced to rely on foreign supplies of life-saving vaccines in the event of an outbreak, but a group of University of Saskatchewan researchers is hoping to change that.
- Government of Canada invests in top research labs
VIDO-InterVac receives additional support from the Canadian Foundation for Innovation's Major Science Initiatives Fund.
- Dr. Andrew Potter receives 2019 Saskatchewan Order of Merit
Dr. Andrew Potter, VIDO-InterVac's former Director and CEO, is one of this year's recipients of the Saskatchewan Order of Merit.
- Lung plague vaccine wins international award
A vaccine against contagious bovine pleuropneumonia (CBPP) won the award for Best Veterinary Vaccine at the 12th World Vaccine Congress in Washington DC.
- Agencies search for ASF vaccine
VIDO-InterVac is helping lead the way developing a vaccine for African swine fever. In May, more than 30 different vaccine candidates for the disease are scheduled for efficacy testing.